Clinical Trials Using Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
Clinical trials are research studies that involve people. The clinical trials on this list are studying Allogeneic GM-CSF-Secreting Breast Cancer Vaccine. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Cyclophosphamide and Vaccine Therapy with or without Trastuzumab in Treating Patients with Stage IV Breast Cancer
This trial studies cyclophosphamide and vaccine therapy with or without trastuzumab in treating patients with stage IV breast cancer. Drugs used in chemotherapy, such as cyclophosphamide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Vaccines made from gene-modified tumor cells may help the body build an effective immune response to kill tumor cells. Immunotherapy with trastuzumab, may induce changes in body’s immune system and may interfere with the ability of tumor cells to grow and spread. It is not yet known whether cyclophosphamide and vaccine therapy is more effective when given together with or without trastuzumab in treating patients with breast cancer.
Location: Johns Hopkins University / Sidney Kimmel Cancer Center, Baltimore, Maryland